Zheng Hui-Da, Huang Qiao-Yi, Hu Yun-Huang, Ye Kai, Xu Jian-Hua
Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, Fujian Province, China.
Department of Gynaecology and Obstetrics, The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, Fujian Province, China.
World J Gastrointest Surg. 2023 Dec 27;15(12):2799-2808. doi: 10.4240/wjgs.v15.i12.2799.
Gastric ectopic pancreas (GEP) is a rare developmental abnormality that refers to the existence of pancreatic tissue in the stomach with no anatomical relationship with the main pancreas. It is usually difficult to diagnose through histological examination, and the choice of treatment method is crucial.
To describe the endoscopic ultrasound characteristics of GEP and evaluate the value of laparoscopic resection (LR) and endoscopic submucosal dissection (ESD).
Forty-nine patients with GEP who underwent ESD and LR in the Second Affiliated Hospital of Fujian Medical University from May 2018 to July 2023 were retrospectively included. Data on clinical characteristics, endoscopic ultrasonography (EUS), ESD, and LR were collected and analyzed. The characteristics of EUS and the efficacy of the two treatments were analyzed.
The average age of the patients was 43.31 ± 13.50 years, and the average maximum diameter of the lesions was 1.55 ± 0.70 cm. The lesion originated from the mucosa in one patient (2.04%), from the submucosa in 42 patients (85.71%), and from the muscularis propria in 6 patients (12.25%). Twenty-nine patients (59.20%) with GEP showed umbilical depression on endoscopy. The most common initial symptom of GEP was abdominal pain (40.82%). Tumor markers, including carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA-19-9), were generally within the normal range. One patient (2.04%) with GEP had increased CEA and CA-19-9 levels. However, no cancer tissue was found on postoperative pathological examination, and tumor markers returned to normal levels after resecting the lesion. There was no significant difference in surgery duration (72.42 ± 23.84 74.17 ± 12.81 min) or hospital stay (3.70 ± 0.91 3.83 ± 0.75 d) between the two methods. LR was more often used for patients with larger tumors and deeper origins. The amount of bleeding was significantly higher in LR than in ESD (11.28 ± 16.87 16.67 ± 8.76 mL, < 0.05). Surgery was associated with complete resection of the lesion without any serious complications; there were no cases of recurrence during the follow-up period.
GEP has unique characteristics in EUS. LR and ESD seem to be good choices for treating GEP. LR is better for large GEP with a deep origin. However, due to the rarity of GEP, multicenter large-scale studies are needed to describe its characteristics and evaluate the safety of LR and ESD.
胃异位胰腺(GEP)是一种罕见的发育异常,指胃内存在与主胰腺无解剖关系的胰腺组织。通常难以通过组织学检查进行诊断,治疗方法的选择至关重要。
描述胃异位胰腺的内镜超声特征,并评估腹腔镜切除术(LR)和内镜黏膜下剥离术(ESD)的价值。
回顾性纳入2018年5月至2023年7月在福建医科大学附属第二医院接受ESD和LR治疗的49例胃异位胰腺患者。收集并分析临床特征、内镜超声检查(EUS)、ESD和LR的数据。分析EUS的特征及两种治疗方法的疗效。
患者的平均年龄为43.31±13.50岁,病变的平均最大直径为1.55±0.70 cm。1例患者(2.04%)的病变起源于黏膜,42例患者(85.71%)起源于黏膜下层,6例患者(12.25%)起源于固有肌层。29例(59.20%)胃异位胰腺患者在内镜检查时表现为脐样凹陷。胃异位胰腺最常见的初始症状是腹痛(40.82%)。包括癌胚抗原(CEA)和糖类抗原19-9(CA-19-9)在内的肿瘤标志物一般在正常范围内。1例(2.04%)胃异位胰腺患者的CEA和CA-19-9水平升高,但术后病理检查未发现癌组织,切除病变后肿瘤标志物恢复正常水平。两种方法在手术时间(72.42±23.84对74.17±12.81分钟)或住院时间(3.70±0.91对3.83±0.75天)方面无显著差异。LR更多用于肿瘤较大且起源较深的患者。LR的出血量明显高于ESD(11.28±16.87对16.67±8.76 mL,P<0.05)。手术均实现病变完全切除,无任何严重并发症;随访期间无复发病例。
胃异位胰腺在内镜超声检查中有独特特征。LR和ESD似乎是治疗胃异位胰腺的良好选择。LR更适合起源较深的大型胃异位胰腺。然而,由于胃异位胰腺罕见,需要多中心大规模研究来描述其特征并评估LR和ESD的安全性。